Proteins take a while to digest, and therefore reach those GLP-1-secreting cells that are further along in the intestinal tract
The ingredients in these supplements often lack the necessary potency and mechanisms to replicate the effects of prescription GLP-1 medications without proper testing, their safety and efficacy are highly questionable, Tambini added
Sources Centers for Medicare & Medicaid Services (CMS)
These findings suggest that the additional GCG agonism in cotadutide provides direct metabolic benefits to hepatocytes beyond those achievable through GLP-1 receptor activation alone, even when caloric restriction is matched [43]
Eating disorders Pre-clinical and mechanistic studies We retrieved only a few pre-clinical and mechanistic articles relevant to GLP-1RAs for eating disorders (Supplementary Section 5)
Considering the potential of secondary bile acids to increase L-cells and GLP-1 secretion by TGR5, TGR5 agonists are promising drug candidates for increasing L-cells and GLP-1 secretion [180, 181]
